News on immunohistochemistry and other tissue-based testing methods.
Scale Venture Partners led the Series B round with participation from Hitachi Ventures. Proscia raised $8.3 million in its Series A round in 2018.
The deal provides clinicians with digital access to Flagship Bio's TissueInsight via Inspirata's Dynamyx digital pathology product.
Promega will develop its microsatellite instability assay as a companion diagnostic for Incyte's anti-PD-1 drug candidate retifanlimab in endometrial cancer.
Cernostics offers an assay that analyzes whole-slide digital images with multiplexed fluorescence to help interpret Barrett's esophagus patient biopsies.
The deal gives Fujifilm global distribution rights to Inspirata's Dynamyx digital pathology workflow software with exclusivity in certain European markets.
